ITMI910314A1 - Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressione di detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine rico - Google Patents

Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressione di detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine rico

Info

Publication number
ITMI910314A1
ITMI910314A1 IT000314A ITMI910314A ITMI910314A1 IT MI910314 A1 ITMI910314 A1 IT MI910314A1 IT 000314 A IT000314 A IT 000314A IT MI910314 A ITMI910314 A IT MI910314A IT MI910314 A1 ITMI910314 A1 IT MI910314A1
Authority
IT
Italy
Prior art keywords
proteins
genes
isolated
serotipo
pctd
Prior art date
Application number
IT000314A
Other languages
English (en)
Inventor
Maurizio Comanducci
Marzia Giuliani
Giulio Ratti
Mario Felice Tecce
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo Spa filed Critical Sclavo Spa
Publication of ITMI910314A0 publication Critical patent/ITMI910314A0/it
Priority to ITMI910314A priority Critical patent/IT1244706B/it
Priority to AT91106110T priority patent/ATE181104T1/de
Priority to ES91106110T priority patent/ES2136062T3/es
Priority to DK91106110T priority patent/DK0499681T3/da
Priority to DE69131319T priority patent/DE69131319T2/de
Priority to EP91106110A priority patent/EP0499681B1/en
Publication of ITMI910314A1 publication Critical patent/ITMI910314A1/it
Application granted granted Critical
Publication of IT1244706B publication Critical patent/IT1244706B/it
Priority to US08/444,189 priority patent/US6110705A/en
Priority to US08/468,544 priority patent/US6248563B1/en
Priority to US08/969,644 priority patent/US6096519A/en
Priority to GR990401491T priority patent/GR3030447T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/125—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ITMI910314A 1991-02-07 1991-02-07 Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici IT1244706B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI910314A IT1244706B (it) 1991-02-07 1991-02-07 Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici
DE69131319T DE69131319T2 (de) 1991-02-07 1991-04-17 Isoliertes PCTD Plasmid aus Chlamydia trachomatis von Serotyp D, dessen Genen und davon kodierten Proteine, rekombinante Plasmide für die Expression von deren Genen als Fusionsproteine in einem keterologen System, und ihre Verwendung als Impfstoff- und/oder Diagnostiekformulierung
ES91106110T ES2136062T3 (es) 1991-02-07 1991-04-17 Plasmido pctd aislado de chlamydia trachomatis serotipo d, genes y proteinas codificados por el mismo; plasmidos recombinantes para la expresion de dichos genes en sistemas heterologos como proteinas recombinantes de fusion, preparacion de dichas proteinas recombinantes y ...
DK91106110T DK0499681T3 (da) 1991-02-07 1991-04-17 pCTD-plasmid isoleret fra Chlamydia trachomatis serotype D, dets gener og proteiner, som kodes af dem; rekombinante plasmid
AT91106110T ATE181104T1 (de) 1991-02-07 1991-04-17 Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung
EP91106110A EP0499681B1 (en) 1991-02-07 1991-04-17 PCTD plasmid isolated from chlamydia trachomatis serotype D, its genes and proteins encoded by them; recombinant plasmids for the expression of said genes in heterologous systems as fused recombinant proteins, preparation of said recombinant proteins and their use in the formulation of vaccines and/or dianostics
US08/444,189 US6110705A (en) 1991-02-07 1995-05-18 Recombinant Chlamydia trachomatis pgp3 fusion protein
US08/468,544 US6248563B1 (en) 1991-02-07 1995-06-06 Chlamydia trachomatis serotype D genes
US08/969,644 US6096519A (en) 1991-02-07 1997-11-13 Chlamydia trachomatis serotype D proteins
GR990401491T GR3030447T3 (en) 1991-02-07 1999-06-10 PCTD plasmid isolated from chlamydia trachomatis serotype D, its genes and proteins encoded by them; recombinant plasmids for the expression of said genes in heterologous systems as fused recombinant proteins, preparation of said recombinant proteins and their use in the formulation of vaccines and/or dianostics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910314A IT1244706B (it) 1991-02-07 1991-02-07 Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici

Publications (3)

Publication Number Publication Date
ITMI910314A0 ITMI910314A0 (it) 1991-02-07
ITMI910314A1 true ITMI910314A1 (it) 1992-08-07
IT1244706B IT1244706B (it) 1994-08-08

Family

ID=11358472

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910314A IT1244706B (it) 1991-02-07 1991-02-07 Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici

Country Status (8)

Country Link
US (2) US6110705A (it)
EP (1) EP0499681B1 (it)
AT (1) ATE181104T1 (it)
DE (1) DE69131319T2 (it)
DK (1) DK0499681T3 (it)
ES (1) ES2136062T3 (it)
GR (1) GR3030447T3 (it)
IT (1) IT1244706B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629167A (en) * 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
US5814490A (en) * 1996-06-11 1998-09-29 Becton, Dickinson And Company Amplification and detection of chlamydia trachomatis nucleic acids
IL119938A (en) * 1996-12-30 2005-08-31 Yissum Res Dev Co Peptides capable of eliciting protective immunity against toxic shock induced by pyrogenic exotoxins or of antagonizing toxin-mediated activation of t cells
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7090973B1 (en) * 1999-04-09 2006-08-15 Oscient Pharmaceuticals Corporation Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
GB0016814D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (3)
JP4413617B2 (ja) 2001-12-12 2010-02-10 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓに対する免疫化
EP2152303A4 (en) * 2007-05-01 2011-10-05 Univ Texas CHLAMYDIA ANTIGENS AS REAGENTS FOR THE DIAGNOSIS AND TREATMENT OF CHLAMYDIA INFECTION AND DISEASE
CA2739111A1 (en) 2008-10-09 2010-04-15 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192033B1 (en) * 1985-01-14 1996-09-25 Chiron Corporation Chlamydia major outer membrane protein
GB8709746D0 (en) * 1987-04-24 1987-05-28 Wenman W M Chlamydia vaccine
IT1224253B (it) * 1988-04-08 1990-09-26 Sclavo Spa Oligonucleotidi sintetici utili per la determinazione di chlamydia trachomatis in un campione biologico

Also Published As

Publication number Publication date
ES2136062T3 (es) 1999-11-16
EP0499681B1 (en) 1999-06-09
US6096519A (en) 2000-08-01
DE69131319T2 (de) 1999-12-16
DE69131319D1 (de) 1999-07-15
DK0499681T3 (da) 1999-11-15
US6110705A (en) 2000-08-29
IT1244706B (it) 1994-08-08
ITMI910314A0 (it) 1991-02-07
ATE181104T1 (de) 1999-06-15
GR3030447T3 (en) 1999-09-30
EP0499681A1 (en) 1992-08-26

Similar Documents

Publication Publication Date Title
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
WO2002012281A3 (en) Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
CA2132836A1 (en) Immunization by inoculation of dna transcription unit
AUPO856097A0 (en) Vector
PL296702A1 (en) Vaccines
CA2395499A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
ITMI910314A1 (it) Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressione di detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine rico
PL303482A1 (en) Vaccine against infection with streptococcus suis, streptococcus suis polypeptide and method of preparing such vaccine
IL116559A0 (en) Chimeric proteins
AU4119996A (en) Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine
KR950704499A (ko) 스트렙토코커스 써모필러스 기원 박테리오신(bacteriocins from streptococcus thermophilus)
CU22222A1 (es) Procedimiento para la expresion de proteinas heterologicas producidas de forma fusionada en escherichia coli, su uso, vectores de expresion y cepas recombinantes
EP0691404A3 (de) Verbesserte Vakzine zur Immunisierung gegen TBE-Virusinfektionen sowie ein Verfahren zu dessen Herstellung
AU1624292A (en) Recombinant vaccine against marek's disease
WO1992003553A1 (en) Footrot vaccine
GB9401795D0 (en) Vaccines
ZA906667B (en) Antigens and polypeptides derived from babesia(12d3 antigen)
EP0433378A4 (en) Allelic variants of -i(plasmodium falciparum) merozoite surface antigen
WO2001079511A2 (en) Hemolysin fusion proteins, their production and use
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970226